Infectious Diseases Division, Rhode Island Hospital Warren Alpert Medical School of Brown University, Providence, Rhode Island Internal Medicine Department, Boston Medical Center, Massachusetts.
Infectious Diseases Division, Rhode Island Hospital Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S630-4. doi: 10.1093/cid/civ816.
Fungal-bacterial interactions are common in the environment. The interactions between invasive fungi (eg, Candida species and Aspergillus species) and pathogenic bacteria can be particularly significant in the outcome of human infections. Study of these interactions in vivo using murine or invertebrate models, such as Caenorhabditis elegans or Galleria mellonella, has been very helpful in increasing our understanding of the pathogenesis of mixed infections and in identifying ways to use this between-kingdom interplay to our advantage. Based on their effect against fungal biofilms and their immunomodulatory properties, the newer class of antifungal agents, known as echinocandins, has the potential to be useful in polymicrobial infections and in high-risk complex infections such as ventilator-associated pneumonia or sepsis where colonization by fungi can lead to worse outcomes.
真菌-细菌相互作用在环境中很常见。侵袭性真菌(例如,念珠菌属和曲霉属)与致病菌之间的相互作用在人类感染的结果中可能特别重要。使用鼠类或无脊椎动物模型(例如秀丽隐杆线虫或家蚕)在体内研究这些相互作用,极大地帮助我们了解混合感染的发病机制,并确定如何利用这种跨界相互作用为我们带来优势。基于其对抗真菌生物膜的作用及其免疫调节特性,新型抗真菌药物,即棘白菌素类,有可能在混合感染和高危复杂感染(例如呼吸机相关性肺炎或败血症)中发挥作用,在这些感染中,真菌定植会导致更糟糕的结果。